---
figid: PMC3584651__IJO-40-04-1259-g05
figlink: /pmc/articles/PMC3584651/figure/f6-ijo-40-04-1259/
number: F6
caption: Schematic representation of RAS/PI3K/mTOR/STAT3 signaling. Constitutively
  active RAS can regulate the STAT3 pathway in dependent of the canonical PI3K/AKT
  pathway. In addition, RAS can directly activate mTOR via RSK-mediated phosphorylation
  of Raptor. mTOR as a kinase fully activates STAT3, which is essential for RAS oncogenic
  transformation. In RAS mutant cancer cells, therefore, despite suppression of PI3K
  by NVP-BKM120, the RAS signaling still enables to maintain oncogenic transformation
  through activation of the mTOR/STAT3 signaling. Combination of NVP-BKM120 and AG490
  may result in a synergistic effect on gastric cancer harboring KRAS mutation.
pmcid: PMC3584651
papertitle: NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor
  in human gastric cancer cells harboring KRAS mutations.
reftext: EUNJU PARK, et al. Int J Oncol. 2012 Apr;40(4):1259-1266.
pmc_ranked_result_index: '10699'
pathway_score: 0.8982409
filename: IJO-40-04-1259-g05.jpg
figtitle: RAS/PI3K/mTOR/STAT3 signaling
year: '2012'
organisms:
- Homo sapiens
ndex: ab5357e6-df13-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3584651__IJO-40-04-1259-g05.html
  '@type': Dataset
  description: Schematic representation of RAS/PI3K/mTOR/STAT3 signaling. Constitutively
    active RAS can regulate the STAT3 pathway in dependent of the canonical PI3K/AKT
    pathway. In addition, RAS can directly activate mTOR via RSK-mediated phosphorylation
    of Raptor. mTOR as a kinase fully activates STAT3, which is essential for RAS
    oncogenic transformation. In RAS mutant cancer cells, therefore, despite suppression
    of PI3K by NVP-BKM120, the RAS signaling still enables to maintain oncogenic transformation
    through activation of the mTOR/STAT3 signaling. Combination of NVP-BKM120 and
    AG490 may result in a synergistic effect on gastric cancer harboring KRAS mutation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - HRAS
  - PIK3R4
  - PIK3R3
  - STAT3
  - MTOR
  - PIK3CA
  - KRAS
  - NRAS
  - AKT2
  - PIK3R6
  - PIK3R5
  - AKT1
  - AKT3
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
chemicals: []
diseases: []
figid_alias: PMC3584651__F6
redirect_from: /figures/PMC3584651__F6
figtype: Figure
---
